The C1831 device category was made effective in the OPPS on October 1, 2021, and expired on September 30, 2024, as such, we cannot reinstate the pass-through payment status of C1831 because reinstatement would make the pass-through payment status effective longer than the maximum 3-year period permitted under section 1833(t)(6)(B)(iii) of the Act and 419.66(g)
There are no risks related to skin tone or tan with CoolSculpting, making it safe for patients of all skin types during all times of the year
Tiene riesgo de promover tumores por su actividad angiognica
Concerns included generalisability of training data, user knowledge requirements, and use in complex cases or cases with incomplete data
Lets make sure to notice the ones that are easily detectable and treatable
Great delivery and customer service,,, will definitely continue with this company